BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2011
View Archived Issues
Phase I study of JVS-100 complete
Read More
First-in-human results presented on PRS-050 in patients with advanced solid malignancies
Read More
Costimulatory fusion protein enhances activity of tumor vaccine in vivo
Read More
Takeda presents new antiatherosclerotic compounds
Read More
Preclinical study assesses antitumor effects of Pfizer's new antibody-drug conjugate
Read More
Medunik Canada acquires Canadian rights to two orphan therapies from QOL Medical
Read More
Idera Pharmaceuticals obtains FDA authorization for IMO-3100 trial
Read More
Anthera Pharmaceuticals completes interim analysis of PEARL-SC study
Read More
Novel PI3K and mTOR inhibitors patented by Spanish researchers
Read More
XTL Biopharmaceuticals acquires MinoGuard
Read More
New apoptosis inhibitors described in Chinese PLA General Hospital patent
Read More
Evotec patents novel orexin OX2 receptor antagonists
Read More
New beta-secretase inhibitors discovered by Roche and Siena Biotech
Read More
Octagam 5% now available again in the U.S.
Read More
Novel caspase-3 activators and apoptosis inducers reported in patent literature
Read More
NovaBay advances phase II NVC-422 study
Read More
FDA grants orphan drug designation to Emergent's TRU-016
Read More
Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907
Read More
Ceregene completes enrollment in second phase II CERE-120 study
Read More
Auxilium Pharmaceuticals doses first patient in Xiaflex study
Read More
Brewer Sports International to fund traumatic brain injury research
Read More
MacroGenics and Servier enter into license agreement for MGA-271
Read More
Celldex Therapeutics begins phase III trial of rindopepimut
Read More
Generex provides update on clinical and regulatory status of buccal insulin spray
Read More
NPS Pharmaceuticals files NDA seeking FDA approval of Gattex
Read More
EMA approves combination antimalarial drug Eurartesim
Read More